Understanding Intimate Partner Violence and Its Impact on Maternal Health in Diverse Communities

In this episode, we delve into a crucial discussion with Larissa Mervin, Managing Attorney at Legal Aid of North Carolina's Charlotte office. Larissa shares her extensive experience in dealing with intimate partner violence (IPV) and its effects on maternal health. We explore the nuanced aspects of IPV, its definition, and the various forms it can take, from physical violence to emotional and financial control.

Larissa sheds light on the impact of IPV on different communities, including Black and Latinx populations, emphasizing the historical and structural factors that contribute to disparities in access to care and support. We also discuss how the COVID-19 pandemic has exacerbated IPV issues, leading to increased court filings and homicides.

This episode provides valuable insights for healthcare providers, social workers, and anyone interested in understanding and addressing the complex challenges surrounding IPV and maternal health, particularly in underserved communities. Join us for this enlightening conversation on a critical public health issue.

Learn more about us, explore our resource center and find support for all maternal health professionals at MaternalHealthLearning.org or MaternalHealthPodcast.org. Maternal Health Innovation is a product of the Maternal Health Learning and Innovation Center and is produced by Earfluence.

Music provided by Graham Makes.

MHLIC collaborates with many organizations and people for content such as the podcasts, videos, and webinar series. The statements, information, and opinions shared may not reflect MHLIC and MHLIC partners. Our team strives to hold ourselves and invited experts accountable, and will address violations to our values and overall mission. Read our full disclaimer here.

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U7CMC33636 State Maternal Health Innovation Support and Implementation Program Cooperative Agreement. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS, or the U.S. Government.